We are pleased to see this litigation moving forward. As we continue to hear from Biomet hip replacement recipients who claim to have suffered hip implant failure and other complications, we look forward to seeing additional progress in this proceeding.
New York, New York (PRWEB) March 31, 2013
Bernstein Liebhard LLP notes the scheduling of the next case management conference in the federal litigation of Biomet hip replacement lawsuits established in the U.S. District Court, Northern District of Indiana. According to a Memorandum issued by the Court on March 20, the status conference will be held April 22nd at 9:30 a.m. Claims filed in this multidistrict litigation were brought on behalf of patients who allege injuries stemming from the metal-on-metal Biomet M2a Magnum hip implant. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
The last status conference in this litigation was held March 18th and discussed a range of issues related to the Biomet M2a Magnum hip replacement, according to the Memorandum. Production of electronically stored information and modifications to the Plaintiffs’ Fact Sheet were among the items addressed.
“We are pleased to see this litigation moving forward. As we continue to hear from Biomet hip replacement recipients who claim to have suffered hip implant failure and other complications, we look forward to seeing additional progress in this proceeding,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices.
The Firm is actively filing Biomet hip lawsuits in the federal litigation on behalf of individuals allegedly injured by the metal-on-metal Biomet M2a Magnum hip replacement.
Biomet Hip Replacement Lawsuits
The Biomet M2a Magnum hip implant is a metal-on-metal hip consisting of a metal femoral head and pelvic cup made of chromium and cobalt. Given the high number of adverse event reports filed with the U.S. Food and Drug Administration (FDA) over metal-on-metal hip implants, the agency proposed a new rule in January that would make this class of devices ineligible to receive market approval via the FDA’s 510(k) clearance process. This approval process allows a product to bypass human testing if the manufacturer can prove it to be substantially equivalent to one already on the market. The agency also issued a new recommendation that patients who received metal-on-metal hip implants consider metal ion testing if they are experiencing symptoms associated with early hip failure.*
Court records indicate there are at least 141 Biomet hip lawsuits pending in the litigation established in the U.S. District Court, Northern District of Indiana. These claims allege the Biomet M2a Magnum hip replacement can cause patients to suffer injuries related to high levels of metal ions, which may lead to metallosis in the surrounding tissue and blood, as well as early failure of the device. The lawyers at Bernstein Liebhard LLP are actively involved in the litigations involving other metal-on-metal hip implant devices as well. In addition to filing lawsuits in the multidistrict litigation currently underway in the U.S. District Court, Northern District of Ohio, for claims involving the DePuy ASR hip implant (MDL No. 2197), The Firm is also directly involved in the federal litigation established in the Northern District of Texas for lawsuits filed over the metal-on-metal DePuy Pinnacle hip device (MDL No. 2244). In this litigation, Firm partner Jeffrey S. Grand is serving on the Plaintiffs’ Steering Committee.
Patients who received metal-on-metal hips and suffered metallosis, hip implant failure and other serious side effects they claim to be caused by the Biomet hip replacement may be eligible to file a claim seeking compensation for medical expenses, lost wages, pain and suffering and other damages incurred by their injuries. To learn more about metal-on-metal hip implant complications and how to file a Biomet hip lawsuit, please visit Bernstein Liebhard’s website. For further information, please contact one of our attorneys today by calling 1-877-779-1414.
About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP